University of Crete (UOC)
Study of the interactions between glucocorticoids and neurotrophins in physiological and neuropathological conditions
Abstract
dc:descriptionGlucocorticoids (GCs), the end product of the hypothalamic-pituitary-adrenal axis and the primary effector hormones of stress, exhibit complex temporal dynamics characterized by both circadian and ultradian rhythmicity that are crucial for maintaining physiological homeostasis and adaptive stress responses. Acting through two types of receptors, the high affinity Mineralocorticoid Receptor (MR) and the Glucocorticoid Receptor (GR), these hormones are considered crucial as mediators of anti-inflammatory effects, which have been extensively studied in immune contexts. However, their role in regulating neuroinflammation, particularly in brain glia cells like astrocytes, remains poorly understood. Astrocytes, the most abundant glial cells in the central nervous system, serve as critical mediators of neuroinflammatory responses and express high levels of glucocorticoid receptors, making them prime targets for GC signaling. However, current research has predominantly focused on static hormone administration paradigms that fail to recapitulate the dynamic nature of physiological GC secretion patterns. This limitation represents a significant gap in understanding how temporal aspects of GC signaling influence astrocytic function and neuroinflammatory responses. Furthermore, the interaction between GC and neurotrophic factors, specifically the main CNS neurotrophin, brain-derived neurotrophic factor (BDNF), two major brain molecules that functionally converge in stress-related brain disorders, has not been systematically investigated in astrocytes. The primary aim of this dissertation was to investigate how different patterns of GC rhythmicity, with particular emphasis on ultradian pulsatility, influence astrocytic biology and neuroinflammatory responses. To address this, four complementary objectives were undertaken. The first objective characterized GC-BDNF interactions in primary mouse astrocytes to understand the mechanistic foundations of stress hormone-neurotrophin crosstalk. The second objective involved the development and validation of a novel microfluidic platform capable of delivering physiologically relevant GC secretion patterns with high temporal and concentration precision. The third objective established a reliable protocol for translating the aforementioned knowledge establishing differentiation protocols of human induced pluripotent stem cells (hiPSCs) towards functional astrocytes and successfully integrating them with the microfluidic system. The fourth objective systematically assessed the impact of distinct GC administration patterns on human astrocytic function, with emphasis on transcriptional regulation, inflammatory responses, and potential implications for protein clearance mechanisms. Our investigation on the GC-BDNF interactions revealed a novel biphasic response pattern in astrocytes that fundamentally differs from neuronal responses. Corticosterone exposure induced rapid BDNF mRNA upregulation within the first hour, mediated by TrkB receptor phosphorylation through non-genomic mechanisms independent of classical GR signaling. The mechanistic analysis demonstrated that corticosterone rapidly phosphorylates TrkB receptors within 20 minutes, reaching peak activation comparable to exogenous BDNF stimulation. Importantly, TrkB inhibition completely abolished the early BDNF upregulation, establishing a causal relationship between rapid receptor phosphorylation and transcriptional activation. This early response was followed by sustained BDNF suppression over 6-24 hours, which proved to be GR-dependent and could be reversed by GR antagonism. This biphasic pattern was normalized by a second corticosterone pulse, highlighting the importance of ultradian rhythmicity in maintaining neurotrophin homeostasis.In order to properly study physiological and pathological human ultradian pulsatility while at the same time increasing the translatability of my results, new innovative methodological approaches had to be employed: a) a microfluidic platform was custom-designed using pressure-controlled pumps, high-accuracy flow sensors, and microfluidic mixing interfaces to generate three distinct GC delivery profiles: physiological pulsatile (Profile 1), steady-state (Profile 2), and aberrant rhythmic patterns (Profile 3) mimicking stress-related disorders and b) human iPSC-derived astrocytes were generated after adaptations on an established differentiation protocol and characterization for astrocytic maturation, morphology, and functional responses. The microfluidic platform successfully reproduced physiologically relevant ultradian GC patterns with unprecedented precision and stability. The system demonstrated the ability to generate consistent 3-hour pulsatile profiles over extended periods (24-48 hours) while maintaining cell viability under carefully controlled shear stress conditions (0.01-0.1 dyne/cm²). Integration with human iPSC-derived astrocytes revealed that these cells express appropriate astrocytic markers, maintain characteristic morphology, and respond appropriately to inflammatory stimuli. Importantly, the hiPSC-astrocytes demonstrated GC responsiveness with GR expression levels significantly higher than MR levels, closely mirroring human brain tissue patterns. The central finding of this research demonstrated that the temporal pattern of GC exposure—specifically ultradian pulsatility versus steady-state delivery—dramatically modulates astrocytic neuroinflammatory responses despite identical cumulative hormone exposure. Physiological pulsatile GC delivery (Profile 1) maintained anti-inflammatory astrocytic phenotypes with minimal cytokine expression, while steady-state administration (Profile 2) triggered robust pro-inflammatory activation characterized by upregulation in IL-6, IL-8, CCL5, IFN-γ and CXCL10 cytokine expression. Aberrant ultradian pulsatile patterns (Profile 3), designed to mimic stress-related disorders, induced similar inflammatory responses. Pharmacological analysis using mifepristone revealed that these differential effects were primarily GR-mediated, with steady exposure promoting sustained GR activation and inflammatory gene transcription.Remarkably, extended exposure experiments (48 hours) revealed evidence for self-resolving inflammatory mechanisms in astrocytes under steady GC conditions. This resolution was associated with compensatory upregulation of GRα at 24 hours and upregulation of IL-1 receptor antagonist (IL1Ra) at 48 hours in the steady administration profile, suggesting intrinsic adaptive mechanisms that attempt to restore homeostatic balance. Furthermore, preliminary analysis of protein clearance markers (AQP4 and LRP1) indicated potential downward trends under non-physiological GC patterns, suggesting implications for astrocytic clearance capacity relevant to neurodegenerative processes. The clinical implications of these findings are substantial, providing mechanistic insights into how disrupted cortisol rhythms contribute to neuroinflammation in stress-related and neurodegenerative disorders. This research validates the therapeutic potential of chronotherapeutic approaches that restore physiological pulsatility rather than simply modulating hormone levels. The methodological innovations, particularly the microfluidic platform, address critical gaps in chronopharmacological research and provide a technological framework for studying temporal aspects of hormone action, while the successful integration of human iPSC-derived astrocytes enhances translational relevance by eliminating species-specific confounding factors. This work advances understanding of astrocyte biology by demonstrating that temporal dynamics of GC signaling represent primary determinants of astrocytic inflammatory responses and adaptive mechanisms. The findings challenge traditional dose-response paradigms of GC action and establish that physiological pulsatility preserves anti-inflammatory phenotypes while aberrant delivery patterns trigger pathological activation. The identification of self-resolving inflammatory mechanisms and their temporal coordination provides new insights into astrocytic homeostatic plasticity. These discoveries contribute to the emerging paradigm of precision medicine and personalized chronotherapy, offering mechanistic evidence that individual differences in cortisol rhythmicity may require personalized therapeutic approaches. The research establishes a methodological framework for investigating temporal drug delivery effects and provides a pathway toward developing chronobiologically informed treatment protocols that optimize therapeutic efficacy while minimizing adverse effects.Importantly, these results could be pharmacologically exploited in the context of neurological disorders characterized by chronic neuroinflammation, such as Alzheimer’s disease and major depressive disorder, by guiding the development of GC-based interventions that restore physiological oscillatory profiles rather than relying on continuous or daily single-dosing. Such chronotherapeutic strategies may improve therapeutic responsiveness, limit detrimental inflammatory signaling, and preserve physiological astrocytic function which is compromised in these conditions. Ultimately, the temporal precision of GC modulation presents a promising avenue for enhancing drug efficacy while minimizing long-term adverse outcomes in vulnerable patient populations.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsimpolis, Alexandros
- Τσιμπόλης, Αλέξανδρος
Subjects
dc:subject × 15- Γλυκοκορτικοειδή και υποδοχέας γλυκοκορτικοειδών GR
- BDNF
- Υπερκιρκάδια παλμικότητα
- Νευροφλεγμονή
- Κατάθλιψη
- Glucocorticoids and glucocorticoid receptor GR
- Ultradian pulsatility
- Neuroinflammation
- Depression
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Φαρμακολογία και Φαρμακευτική
- Basic Medicine
- Medical and Health Sciences
- Pharmacology and Pharmacy
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60296